Roundup Products Liability Litigation
Scientific evidence supports a causative link between glyphosate exposure and increased risk of non-Hodgkin lymphoma. Meta-analyses and mechanistic studies indicate glyphosate's genotoxic potential and immune dysregulation as plausible mechanisms. Expert testimonies in court have reinforced this causation hypothesis, with epidemiological data showing a statistically significant association between glyphosate-based herbicide exposure and NHL risk.
3,920
Pending actions
5,308
Total actions filed
Active
Status
10/03/2016
Established
Who qualifies
Plaintiffs must have developed NHL after documented exposure to Roundup. Exposure generally involves regular use over extended periods, often several years. Specific subtypes like diffuse large B-cell lymphoma are also recognized. Exact dosage and precise exposure timeframes vary case by case but typically include evidence of frequent or heavy use, such as weekly or daily application over multiple years.
Products involved
- Glyphosate-based formulations including Roundup Original, Roundup Weed & Grass Killer
Alleged injuries
- Non-Hodgkin lymphoma (NHL)
- Other lymphatic cancers
This page is generated from the official JPML pending-MDL report and public court records, refreshed monthly. It is provided for attorney reference and is not legal advice.
